Rongwei Liu, Haiyuan Li, Changwen Liu, Jinbo Peng, Ruizhi Gao, Hong Yang, Yun He
{"title":"结合临床和超声特征、超声放射组学和深度迁移学习的综合模型预测甲状腺囊性实性结节的恶性风险。","authors":"Rongwei Liu, Haiyuan Li, Changwen Liu, Jinbo Peng, Ruizhi Gao, Hong Yang, Yun He","doi":"10.21037/gs-2024-551","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The risk of malignancy in cystic-solid thyroid nodules (CSTN) varies greatly and may be underestimated. This study aimed to explore the value of a comprehensive model that integrates deep transfer learning (DTL), ultrasound radiomics, and clinical, and ultrasound features in predicting the risk of malignancy of CSTN.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 278 patients with CSTN confirmed by pathology from the First Affiliated Hospital of Guangxi Medical University from January 2023 to December 2023. Radiomics features were manually extracted from ultrasound images, and DTL features were extracted using deep learning networks. The least absolute shrinkage and selection operator (LASSO) regression was utilized to select non-zero coefficient features from radiomics and DTL features. The comprehensive model nomogram was constructed using a logistic regression algorithm that integrates clinical, ultrasound features, deep learning, and radiomics features. The predictive performance was assessed using the receiver operating characteristic (ROC) curve and the area under the curve (AUC), calibration curves, and decision curves. Subsequently, DeLong testing was performed for comparative analysis of the AUC, with parameter estimates including a 95% confidence interval (CI), and a P value of less than 0.05 was considered statistically significant.</p><p><strong>Results: </strong>The AUC of each model was compared, revealing that the comprehensive model outperformed the individual models in predicting the malignancy risk of CSTN, demonstrating good predictive performance with sensitivity and specificity of 87.50% and 82.90%, respectively. Additionally, the AUC of the comprehensive model in the testing set was 0.913 (95% CI: 0.844-0.982), which was higher than the radiomics model (0.913 <i>vs.</i> 0.898, P=0.67), and the DTL model (0.913 <i>vs.</i> 0.848, P=0.38). In the training set, the AUC was 0.973 (95% CI: 0.949-0.997), outperforming the radiomics model (0.973 <i>vs.</i> 0.926, P=0.09) and the DTL model (0.973 <i>vs.</i> 0.943, P=0.01).</p><p><strong>Conclusions: </strong>The novel comprehensive model based on ultrasound demonstrates excellent performance in predicting the malignancy risk of CSTN, providing clinicians with a preoperative non-invasive screening method to predict the malignancy risk of CSTN.</p>","PeriodicalId":12760,"journal":{"name":"Gland surgery","volume":"14 4","pages":"584-596"},"PeriodicalIF":1.5000,"publicationDate":"2025-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093167/pdf/","citationCount":"0","resultStr":"{\"title\":\"Malignant risk prediction of cystic-solid thyroid nodules using a comprehensive model integrating clinical and ultrasound features, ultrasound radiomics, and deep transfer learning.\",\"authors\":\"Rongwei Liu, Haiyuan Li, Changwen Liu, Jinbo Peng, Ruizhi Gao, Hong Yang, Yun He\",\"doi\":\"10.21037/gs-2024-551\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The risk of malignancy in cystic-solid thyroid nodules (CSTN) varies greatly and may be underestimated. This study aimed to explore the value of a comprehensive model that integrates deep transfer learning (DTL), ultrasound radiomics, and clinical, and ultrasound features in predicting the risk of malignancy of CSTN.</p><p><strong>Methods: </strong>A retrospective analysis was conducted on 278 patients with CSTN confirmed by pathology from the First Affiliated Hospital of Guangxi Medical University from January 2023 to December 2023. Radiomics features were manually extracted from ultrasound images, and DTL features were extracted using deep learning networks. The least absolute shrinkage and selection operator (LASSO) regression was utilized to select non-zero coefficient features from radiomics and DTL features. The comprehensive model nomogram was constructed using a logistic regression algorithm that integrates clinical, ultrasound features, deep learning, and radiomics features. The predictive performance was assessed using the receiver operating characteristic (ROC) curve and the area under the curve (AUC), calibration curves, and decision curves. Subsequently, DeLong testing was performed for comparative analysis of the AUC, with parameter estimates including a 95% confidence interval (CI), and a P value of less than 0.05 was considered statistically significant.</p><p><strong>Results: </strong>The AUC of each model was compared, revealing that the comprehensive model outperformed the individual models in predicting the malignancy risk of CSTN, demonstrating good predictive performance with sensitivity and specificity of 87.50% and 82.90%, respectively. Additionally, the AUC of the comprehensive model in the testing set was 0.913 (95% CI: 0.844-0.982), which was higher than the radiomics model (0.913 <i>vs.</i> 0.898, P=0.67), and the DTL model (0.913 <i>vs.</i> 0.848, P=0.38). In the training set, the AUC was 0.973 (95% CI: 0.949-0.997), outperforming the radiomics model (0.973 <i>vs.</i> 0.926, P=0.09) and the DTL model (0.973 <i>vs.</i> 0.943, P=0.01).</p><p><strong>Conclusions: </strong>The novel comprehensive model based on ultrasound demonstrates excellent performance in predicting the malignancy risk of CSTN, providing clinicians with a preoperative non-invasive screening method to predict the malignancy risk of CSTN.</p>\",\"PeriodicalId\":12760,\"journal\":{\"name\":\"Gland surgery\",\"volume\":\"14 4\",\"pages\":\"584-596\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-04-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12093167/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Gland surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.21037/gs-2024-551\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/25 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gland surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/gs-2024-551","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/25 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
摘要
背景:囊性甲状腺实性结节(CSTN)发生恶性肿瘤的风险差异很大,可能被低估。本研究旨在探讨将深度迁移学习(DTL)、超声放射组学、临床和超声特征相结合的综合模型在预测CSTN恶性风险中的价值。方法:回顾性分析广西医科大学第一附属医院2023年1月至2023年12月经病理证实的CSTN患者278例。人工从超声图像中提取放射组学特征,使用深度学习网络提取DTL特征。利用最小绝对收缩和选择算子(LASSO)回归从放射组学和DTL特征中选择非零系数特征。采用综合临床、超声、深度学习和放射组学特征的逻辑回归算法构建综合模型nomogram。采用受试者工作特征(ROC)曲线、曲线下面积(AUC)、校准曲线和决策曲线评估预测效果。随后进行DeLong检验对AUC进行比较分析,参数估计包括95%置信区间(CI), P值小于0.05认为具有统计学意义。结果:比较各模型的AUC,综合模型预测CSTN恶性风险优于单项模型,预测效果较好,敏感性为87.50%,特异性为82.90%。综合模型在检验集中的AUC为0.913 (95% CI: 0.844 ~ 0.982),高于放射组学模型(0.913 vs. 0.898, P=0.67)和DTL模型(0.913 vs. 0.848, P=0.38)。在训练集中,AUC为0.973 (95% CI: 0.949 ~ 0.997),优于放射组学模型(0.973 vs. 0.926, P=0.09)和DTL模型(0.973 vs. 0.943, P=0.01)。结论:基于超声的新型CSTN综合模型在预测CSTN恶性风险方面表现出色,为临床医生预测CSTN恶性风险提供了一种术前无创筛查方法。
Malignant risk prediction of cystic-solid thyroid nodules using a comprehensive model integrating clinical and ultrasound features, ultrasound radiomics, and deep transfer learning.
Background: The risk of malignancy in cystic-solid thyroid nodules (CSTN) varies greatly and may be underestimated. This study aimed to explore the value of a comprehensive model that integrates deep transfer learning (DTL), ultrasound radiomics, and clinical, and ultrasound features in predicting the risk of malignancy of CSTN.
Methods: A retrospective analysis was conducted on 278 patients with CSTN confirmed by pathology from the First Affiliated Hospital of Guangxi Medical University from January 2023 to December 2023. Radiomics features were manually extracted from ultrasound images, and DTL features were extracted using deep learning networks. The least absolute shrinkage and selection operator (LASSO) regression was utilized to select non-zero coefficient features from radiomics and DTL features. The comprehensive model nomogram was constructed using a logistic regression algorithm that integrates clinical, ultrasound features, deep learning, and radiomics features. The predictive performance was assessed using the receiver operating characteristic (ROC) curve and the area under the curve (AUC), calibration curves, and decision curves. Subsequently, DeLong testing was performed for comparative analysis of the AUC, with parameter estimates including a 95% confidence interval (CI), and a P value of less than 0.05 was considered statistically significant.
Results: The AUC of each model was compared, revealing that the comprehensive model outperformed the individual models in predicting the malignancy risk of CSTN, demonstrating good predictive performance with sensitivity and specificity of 87.50% and 82.90%, respectively. Additionally, the AUC of the comprehensive model in the testing set was 0.913 (95% CI: 0.844-0.982), which was higher than the radiomics model (0.913 vs. 0.898, P=0.67), and the DTL model (0.913 vs. 0.848, P=0.38). In the training set, the AUC was 0.973 (95% CI: 0.949-0.997), outperforming the radiomics model (0.973 vs. 0.926, P=0.09) and the DTL model (0.973 vs. 0.943, P=0.01).
Conclusions: The novel comprehensive model based on ultrasound demonstrates excellent performance in predicting the malignancy risk of CSTN, providing clinicians with a preoperative non-invasive screening method to predict the malignancy risk of CSTN.
期刊介绍:
Gland Surgery (Gland Surg; GS, Print ISSN 2227-684X; Online ISSN 2227-8575) being indexed by PubMed/PubMed Central, is an open access, peer-review journal launched at May of 2012, published bio-monthly since February 2015.